已收盤 12-24 16:00:00 美东时间
+0.670
+0.86%
BioMarin to acquire Amicus for $4.8 billion as analysts see $1 billion peak sales assets, EPS accretion, and stronger long-term rare disease growth.
12-24 02:05
PTC will now engage in pricing discussions which are expected to conclude in Q1 2026, with launch occurring shortly thereafter. First Japan product approval for PTC
12-22 20:08
WARREN, N.J., Dec. 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 16, 2025, the company approved non-statutory stock options to purchase an aggre...
12-20 05:30
BofA analysts outlined a list of inexpensive small- and mid-cap stocks with accelerating fundamentals. These are Russell 2000 (IWM) stocks that have cheap valuations along with positive revisions and ...
12-20 00:57
- Broad label includes all age groups and full range of PKU subtypes -TORONTO, Dec. 10, 2025 /CNW/ - PTC Therapeutics Canada ULC announced that Health Canada has approved Sephience™ (sepiapterin) for the
12-10 21:09
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
Sandisk is joining the S&P 500 Index, prompting a boost in the share price Monday after market close.
11-25 06:59
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251124-1480959/1480959_ipg-pinc-hbi-56.pdf
11-25 06:22
Event to take place on Dec. 2, 2025 in New York City WARREN, N.J., Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&D Day to discuss...
11-20 21:00
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55